'Excellent safety' of 2 indigenous COVID candidate vaccines revealed during Phase-I trials: Minister

Serum Institute of India (SII) and ICMR have partnered for clinical development of two global vaccine candidates.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3mjRawB
via IFTTT